Release of Blood, Brain and Metabolic Human Protein Atlases


As part of The Human Protein Atlas program, three new atlases are being released.

The novel databases cover all proteins in blood, brain and metabolism, respectively, and will be made public during a release event on September 5. The r will feature presentations of data findings from the new atlases, opportunities to ask questions, and a celebration mingle. To register your participation, please fill in the form below. 


Venue: Gamma 2, SciLifeLab Campus Solna

Host: Mathias Uhlén, Professor KTH Royal Institute of Technology and The Human Protein Atlas program Director


The Human Protein Atlas is a program based at SciLifeLab that started in 2003 with the aim to map of all the human proteins in cells, tissues and organs using integration of various omics technologies, including antibody – based imaging, mass spectrometry – based proteomics, transcriptomics and systems biology. All the data in the knowledge resource is open access to allow scientists both in academia and industry to freely access the data for exploration of the human proteome. The current version consists of three separate parts, each focusing on a particular aspect of analysis of the human proteins; including the Tissue Atlas showing the distribution of the proteins across all major tissues and organs in the human body, the Cell Atlas showing the subcellular localization of proteins in single cells, and the Pathology Atlas showing the impact of protein levels for survival of patients with cancer. The new version (version 19) adds three new parts to the resource, a Blood Atlas showing the profiles of blood cells and proteins in the blood, a Brain Atlas showing the distribution of proteins in human, mouse and pig brain and the Metabolic Atlas showing the presence of metabolic pathways across human tissues. The latter is a collaboration with Chalmers University. The Human Protein Atlas program has already contributed to several thousands of publications in the field of human biology and disease and it has been selected by the organization ELIXIR ( as a European core resource due to its fundamental importance for a wider life science community. The HPA consortium is funded by the Knut and Alice Wallenberg Foundation.



Event is full. Registration closed. Contact in case of questions.